Found: 8
Select item for more details and to access through your institution.
SMAD4 Positive Pancreatic Ductal Adenocarcinomas Are Associated with Better Outcomes in Patients Receiving FOLFIRINOX-Based Neoadjuvant Therapy.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3765, doi. 10.3390/cancers15153765
- By:
- Publication type:
- Article
The Role of SMAD4 Inactivation in Epithelial–Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 973, doi. 10.3390/cancers14040973
- By:
- Publication type:
- Article
SARS-Cov-2 infection and neuropathological findings: a report of 18 cases and review of the literature.
- Published in:
- Acta Neuropathologica Communications, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40478-023-01566-1
- By:
- Publication type:
- Article
Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Dabrafenib monotherapy for a recurrent BRAFV600E-mutated TTF-1-positive posterior pituitary tumor.
- Published in:
- Acta Neurochirurgica, 2022, v. 164, n. 3, p. 737, doi. 10.1007/s00701-022-05109-w
- By:
- Publication type:
- Article
Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study